Metronidazol Fresenius

Metronidazole, the active ingredient in Metronidazol Fresenius, is a nitroimidazole antibiotic presented as an intravenous solution for intravenous use. It treats anaerobic bacterial infections and certain protozoal infections in adult patients. GNH USA supplies Metronidazol Fresenius as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

Metronidazole is a nitroimidazole antibiotic used to treat infections caused by anaerobic bacteria and specific protozoa.

- Anaerobic bacterial infections: effective against mixed anaerobic infections in abdominal, pelvic and soft‑tissue sites. - Intra‑abdominal infections: helps resolve peritonitis and postoperative intra‑abdominal sepsis. - Pelvic inflammatory disease: targets anaerobic organisms contributing to PID. - Bacterial vaginosis: reduces overgrowth of anaerobic vaginal flora. - Protozoal infections such as giardiasis and trichomoniasis: eradicates the causative protozoa.

Metronidazole may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Metallic taste: transient alteration of taste perception. - Headache: occasional mild headache. - Diarrhea: loose stools during therapy.

Serious or Rare Side Effects: - Seizures: rare neurologic events. - Peripheral neuropathy: tingling or numbness in extremities. - Severe allergic reactions: anaphylaxis or angioedema. - Stevens‑Johnson syndrome: severe skin and mucous membrane reaction.

Metronidazole requires careful consideration of patient factors and handling. - Pregnancy: use only if benefits outweigh potential risks. - Renal impairment: monitor renal function and adjust therapy as needed. - Hepatic impairment: exercise caution; monitor liver enzymes. - Alcohol consumption: avoid during and 48 hours after treatment to prevent disulfiram‑like reaction. - Concurrent anticoagulants: monitor coagulation parameters for increased bleeding risk. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Metronidazole can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Alcohol: may cause severe disulfiram‑like reaction. - Warfarin: increased anticoagulant effect, monitor INR closely. - Lithium: potential rise in lithium levels, monitor serum lithium.

Moderate Interactions (Monitor Closely): - Cimetidine: may raise metronidazole concentrations, watch for toxicity. - Phenytoin: may reduce metronidazole effectiveness, assess clinical response.